Literature DB >> 21667322

Fatal pneumonitis after treatment with pegylated liposomal doxorubicin in a patient with metastatic breast cancer in complete remission.

Michael Mark, Beat Thürlimann.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 21667322     DOI： 10.1007/s12032-011-0002-1

Source DB:  PubMed          Journal:  Med Oncol        ISSN： 1357-0560            Impact factor:   3.064


× No keyword cloud information.
  3 in total

1.  Interstitial pneumonitis after treatment with bevacizumab and pegylated liposomal doxorubicin in a patient with metastatic breast cancer.

Authors:  Jens Huober; Otto Schoch; Arnoud Templeton; Christian Spirig; Beat Thürlimann
Journal:  Chemotherapy       Date:  2010-02-08       Impact factor: 2.544

2.  Interstitial pneumonitis induced by pegylated liposomal doxorubicin in a patient with recurrent ovarian cancer.

Authors:  Kanako Inaba; Takahide Arimoto; Mari Hoya; Kei Kawana; Shunsuke Nakagawa; Shiro Kozuma; Yuji Taketani
Journal:  Med Oncol       Date:  2011-03-10       Impact factor: 3.064

3.  A phase II study of combination chemotherapy in early relapsed epithelial ovarian cancer using gemcitabine and pegylated liposomal doxorubicin.

Authors:  Mansoor Raza Mirza; Bente Lund; Jacob Christian Lindegaard; Nina Keldsen; Anders Mellemgaard; René Depont Christensen; Kamma Bertelsen
Journal:  Gynecol Oncol       Date:  2010-07-17       Impact factor: 5.482
  3 in total
  4 in total

1.  Inhalable PEGylated Phospholipid Nanocarriers and PEGylated Therapeutics for Respiratory Delivery as Aerosolized Colloidal Dispersions and Dry Powder Inhalers.

Authors:  Priya Muralidharan; Evan Mallory; Monica Malapit; Don Hayes; Heidi M Mansour
Journal:  Pharmaceutics       Date:  2014-06-20       Impact factor: 6.321

2.  Pulmonary Fibrosis after Pegylated Liposomal Doxorubicin in Elderly Patient with Cutaneous Angiosarcoma.

Authors:  Marco Mazzotta; Raffaele Giusti; Daniela Iacono; Salvatore Lauro; Paolo Marchetti
Journal:  Case Rep Oncol Med       Date:  2016-01-20

3.  Drug-Induced Interstitial Lung Disease after Anthracycline-Combined Chemotherapy for Breast Cancer: A Case Report and Literature Review.

Authors:  Hideko Hoshina; Hiroyuki Takei
Journal:  Case Rep Oncol       Date:  2021-11-25

4.  Serpine 1 induces alveolar type II cell senescence through activating p53-p21-Rb pathway in fibrotic lung disease.

Authors:  Chunsun Jiang; Gang Liu; Tracy Luckhardt; Veena Antony; Yong Zhou; A Brent Carter; Victor J Thannickal; Rui-Ming Liu
Journal:  Aging Cell       Date:  2017-07-19       Impact factor: 9.304
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.